To explore the role of FOXM1 in paclitaxel treatment, FoxM1-deleted breast cancer line MEFs were used, results showed that cell viability was decreased and cellular senescence was increased in response to paclitaxel treatment [79]. Here, FOXM1 is linked to breast carcinoma.